dendrit
cell
dc
recogn
essenti
regul
innat
acquir
arm
immun
system
dendrit
cell
addit
distinct
morpholog
number
phenotyp
function
characterist
make
formid
apc
tabl
dendrit
cell
bear
sole
respons
stimul
virgin
lymphocyt
properti
distinguish
apc
eg
b
cell
dc
also
essenti
accessori
cell
gener
primari
antibodi
respons
power
enhanc
nk
cell
cytotox
convers
dc
also
involv
mainten
toler
antigen
dc
thymu
contribut
toward
shape
cell
repertoir
delet
autoreact
lymphocyt
consequ
heterogen
vivo
acknowledg
dc
famili
cell
subset
exert
control
differ
area
immun
term
origin
dc
bone
marrow
deriv
cell
origin
myeloid
lymphoid
precursor
exampl
dc
vivo
includ
epiderm
langerhan
cell
interstiti
dc
found
heart
lung
liver
organ
veil
dc
found
affer
lymph
interdigit
dc
found
area
lymphoid
tissu
thymic
dc
follicular
dc
fdc
except
group
believ
involv
mainten
b
cell
memori
retain
immun
complex
cell
differ
markedli
aforement
group
discuss
review
tew
et
al
main
function
langerhan
interstiti
type
dc
immunolog
sentinel
strateg
place
detect
invad
microb
sentinel
dc
remain
dormant
signal
extracellular
milieu
deriv
either
microb
distress
bystand
cell
induc
rapid
chang
function
also
known
activ
activ
induc
number
import
chang
dc
figur
least
migrat
local
lymphoid
tissu
commun
antigen
inform
lymphocyt
recent
clarif
biochemistri
activ
signal
effect
dc
activ
prompt
research
part
play
activ
dc
pathogenesi
diseas
whether
immunotherapi
use
treatment
wide
rang
diseas
includ
autoimmun
allergi
immunodefici
transplant
reject
persist
viral
infect
cancer
dendrit
cell
initi
character
basi
distinct
morpholog
numer
cytoplasm
process
give
rise
stellat
appear
consequ
dc
high
surfac
area
permit
intim
contact
larg
number
surround
cell
proof
point
vitro
dc
form
larg
spheric
aggreg
lymphocyt
experiment
one
matur
dc
requir
stimul
cell
dendrit
cell
also
possess
array
mechan
sampl
antigen
includ
macropinocytosi
fluid
extracellular
milieu
taken
pinocyt
vesicl
antigen
concentr
expel
excess
water
via
channel
call
aquaporin
dc
also
express
repertoir
receptor
effici
antigen
uptak
addit
receptor
express
dc
includ
bi
complement
receptor
increas
effici
immun
complex
endocytosi
dendrit
cell
express
lectin
receptor
includ
macrophag
mannos
receptor
bind
bacteri
carboydr
dendrit
cell
also
express
markedli
higher
level
antigen
present
molecul
cell
eg
addit
dc
high
surfac
densiti
accessorycostimulatori
molecul
includ
intercellular
adhes
molecul
icam
leucocyt
function
antigen
lfa
figur
facilit
interact
stimul
lymphocyt
addit
noteworthi
properti
dc
exogen
antigen
eg
immun
complex
cross
prime
mhc
class
present
pathway
pathway
would
normal
present
antigen
endogen
compart
dc
thought
possess
specif
mechan
allow
fluid
endocyt
vesicl
gain
direct
access
cytoplasm
essenc
allow
dc
present
new
peptid
lymphocyt
without
infect
damag
throughout
evolut
presenc
pathogen
accompani
seri
uniqu
marker
exampl
may
dsrna
influenza
viru
lp
case
bacteria
dc
sensit
wide
rang
stimuli
serv
activ
innat
immun
via
releas
chemokin
proinflammatori
mediat
also
trigger
dc
migrat
toward
local
lymphoid
tissu
order
gener
adapt
immun
hardli
surpris
intact
viabl
microb
influenza
viru
mycobacteria
observ
activ
dc
howev
question
remain
individu
molecul
mediat
dc
activ
via
receptor
factor
specif
bacteria
lp
surprisingli
cpg
motif
dna
shown
activ
dc
activ
mediat
act
concert
recent
describ
receptor
tlr
howev
receptor
mediat
activ
still
remain
identifi
ligat
fc
receptor
uptak
immun
complex
also
shown
induc
matur
dendrit
cell
interest
observ
sever
factor
includ
lp
abl
rescu
immatur
dc
apoptosi
second
group
signal
deriv
distress
die
cell
phenomenon
langerhan
cell
migrat
tissu
cultur
media
vitro
cultur
skin
explant
h
thought
reflect
inflammatori
stimuli
result
skin
damag
promulg
dc
migrat
cell
consequ
infect
releas
pool
factor
indirectli
activ
dc
action
cytokin
prostaglandin
immatur
dc
produc
matur
event
character
increas
level
membran
reduct
propens
cell
take
solubl
antigen
addit
dc
encount
apoptot
cell
undergo
matur
vitro
matur
involv
autocrineparacrin
secret
thought
mediat
integrin
one
primari
event
activ
releas
chemokin
rant
monocyt
chemotact
protein
mcp
macrophag
inflammatori
protein
mip
attract
new
mononuclear
cell
includ
dc
precursor
also
serv
activ
nk
cell
support
infer
dc
import
bridg
acquir
innat
immun
system
phenomena
accompani
infect
includ
reduct
chemotact
respons
dc
toward
rant
fmlp
increas
chemotact
respons
toward
chemokin
stromal
factor
sdf
chemokin
mdc
chemokin
play
import
role
target
dc
lymphoid
tissu
chemokin
receptor
gradual
activ
ligand
receptor
chemoattract
dc
produc
primarili
parafollicular
area
lymphoid
tissu
langerhan
cell
activ
also
accompani
loss
specif
marker
cutan
lymphocyt
antigen
cla
birbeck
granul
along
alter
surfac
express
cell
adhes
molecul
facilit
movement
affer
lymph
exampl
langerhan
cell
express
mediat
homotyp
interact
keratinocyt
product
molecul
matur
mhc
class
ii
molecul
store
within
vesicl
term
miic
transport
cell
surfac
concomit
increas
surfac
mhc
class
mhc
class
ii
molecul
chang
serv
chang
immatur
dc
adept
antigen
sampl
dc
dedic
present
antigen
immedi
exposur
activ
signal
increas
antigen
uptak
follow
almost
complet
cessat
uptak
preced
migrat
affer
lymphat
summari
dc
activ
accompani
number
chang
includ
increas
express
costimulatori
antigen
present
molecul
decreas
propens
captur
solubl
antigen
increas
stabil
mhc
class
ii
molecul
chang
chemokin
ligand
receptor
express
transloc
lymphoid
tissu
insid
lymphoid
tissu
dc
interact
b
nk
cell
uniqu
abil
dc
attract
stimul
cell
point
still
poorli
understood
howev
appear
dc
secret
chemokin
select
attract
cell
dc
activ
b
cell
produc
chemokin
attract
matur
cell
dendrit
cell
virtu
high
level
surfac
costimul
express
readili
cluster
helper
cell
two
differ
subset
dendrit
cell
recent
character
control
fate
helper
cell
one
subset
design
secret
larg
quantiti
promot
develop
phenotyp
import
gener
immun
intracellular
parasit
anoth
subset
promot
pattern
cytokin
product
via
releas
yet
uncharacter
factor
respons
import
gener
immun
extracellular
infect
also
allerg
respons
interact
complex
signific
effect
cytokin
product
dc
one
import
enhanc
product
express
helper
cell
stimul
product
dc
secret
cytokin
dc
import
enhanc
gener
cytotox
cell
cell
pathway
mani
import
function
context
dc
interact
nk
cell
also
shown
enhanc
nk
cell
cytotox
product
dendrit
cell
also
interact
directli
indirectli
b
cell
allud
previous
one
first
observ
made
regard
dc
essenti
accessori
cell
gener
primari
antibodi
respons
addit
dc
cultur
b
cell
promot
cluster
prove
dcb
cell
commun
mediat
sole
via
th
cell
intermedi
dc
stimul
prolifer
b
cell
also
enhanc
matur
plasma
cell
differenti
b
cell
plasma
cell
depend
dc
secret
presenc
dc
also
observ
promot
immunoglobulin
class
switch
toward
iga
final
stage
dc
life
cycl
apoptosi
mediat
either
lymphocyt
nk
cell
process
make
way
next
wave
dc
migrat
local
tissu
affer
lymph
provid
explan
dc
never
found
effer
lymph
summari
immatur
dc
activ
number
environment
signal
associ
cellular
stress
presenc
microb
signal
transduc
dc
costimul
cytokin
chemokin
activ
innat
acquir
immun
dendrit
cell
commonli
first
immunolog
cell
encount
foreign
organ
surprisingli
dc
play
import
role
gener
protect
immun
toward
intracellular
parasit
howev
consequ
dc
function
may
also
subvert
part
life
cycl
pathogen
number
virus
use
molecul
express
dc
receptor
exampl
includ
hiv
coronaviru
cytomegaloviru
measl
viru
mv
extens
studi
exampl
dc
involv
infect
hiv
lentiviru
remain
latent
dc
exploit
traffick
dc
toward
lymphoid
tissu
strategi
enhanc
infect
permiss
lymphocyt
hiv
appear
activ
dc
ligat
presenc
th
cell
activ
statu
dc
thought
impact
viral
replic
immatur
cutan
dc
support
product
infect
macrophag
tropic
viru
matur
dc
abl
transport
hiv
appear
unabl
replic
cell
macrophag
tropic
strain
viru
interest
observ
virus
deriv
infect
dc
carri
factor
make
highli
infecti
mechan
use
hiv
subvert
antigen
present
dc
undoubtedli
direct
parallel
viral
infect
exampl
activ
dc
cell
result
profound
viral
replic
event
ultim
lead
cell
death
aforement
activ
dc
occur
primarili
lymph
node
appear
mechan
prevent
dc
success
present
antigen
cell
mechan
interf
directli
antigen
present
use
adenovirus
ebv
cmv
may
also
prevent
dc
effect
modul
ctl
respons
exampl
mani
human
herpesvirus
includ
ebv
encod
viral
homologu
suppress
abil
profession
apc
dc
produc
effect
ctl
respons
human
cytomegaloviru
hcmv
caus
sever
morbid
immunocompromis
patient
subvert
immunosurveil
use
latent
replic
stage
human
cytomegaloviru
remain
latent
myeloid
progenitor
monocyt
dendrit
cell
reactiv
observ
cell
treat
cytokin
promot
differenti
dc
coloni
stimul
factor
reactiv
influenc
signal
would
ideal
mechan
interf
antigen
present
inadequ
abil
langerhan
cell
express
hepat
c
viru
gene
thought
reflect
activ
interfer
antigen
present
indetermin
mechan
perhap
involv
perturb
product
pictur
intracellular
parasit
somewhat
similar
effect
immun
respons
essenti
gener
immun
toward
parasit
histoplasma
leishmania
mycobacterium
spp
appear
dc
secret
cytokin
inhibit
infect
parasit
microb
sexual
transmit
intracellular
pathogen
chlamydia
spp
detect
dc
although
mechan
afford
organ
rel
freedom
immunosurveil
still
remain
clarifi
salmonella
sp
recent
discov
infect
surviv
within
dc
hiv
may
import
mechan
dissemin
diseas
away
mucos
site
summari
mani
organ
use
dc
base
evas
immunosurveil
subvers
dc
antigen
present
activ
newli
recogn
phenomenon
help
explain
persist
natur
infect
dendrit
cell
studi
number
common
autoimmun
condit
despit
divers
natur
tissu
distribut
autoimmun
diseas
dc
share
certain
common
characterist
irrespect
diseas
site
recov
includ
increas
number
tissu
dc
particularli
perivascular
distribut
dc
infiltr
earliest
stage
diseas
alter
dc
phenotyp
earli
dc
infiltr
contribut
recruit
immun
cell
rheumatoid
arthriti
ra
chronic
destruct
autoimmun
diseas
poorli
defin
pathogenesi
preval
approach
almost
two
decad
helper
cell
consid
mediat
immun
respons
lead
joint
destruct
base
strong
hla
associ
ra
histolog
featur
synovium
trend
toward
respons
ra
therapi
howev
primaci
cell
ra
challeng
sever
author
investig
dc
express
function
ra
increas
number
dc
shown
peripher
blood
synovi
fluid
exud
synovi
tissu
patient
ra
argu
ra
due
dc
present
endogen
self
peptid
feasibl
hypothesi
import
question
factor
result
synovi
dc
activ
abund
synovium
could
contribut
activ
could
mechan
factor
trauma
mediat
could
synovium
direct
fc
moieti
immunoglobulin
could
lead
macrophag
activ
complement
plethora
cellular
molecular
abnorm
report
ra
could
therefor
secondari
ravag
chronic
inflamm
rather
primari
pathogen
import
therapi
excit
develop
treatment
ra
sustain
immunomodulatori
effect
therapi
earli
ra
could
due
modul
dc
function
regul
costimulatori
signal
dc
traffick
seroneg
polyarthr
includ
relat
condit
ankylos
spondyl
reactiv
arthriti
rea
psoriat
arthriti
undifferenti
arthriti
divers
clinic
entiti
interrel
clinic
spinal
inflamm
immunolog
level
presenc
mhc
class
molecul
hla
hla
transgen
rat
model
evid
dc
play
critic
function
diseas
transfer
bone
marrow
cell
presum
dc
put
activ
signal
seroneg
arthriti
identifi
bacteria
may
preferenti
home
joint
tissu
activ
immun
respons
anoth
signal
could
induc
similar
diseas
phenotyp
experiment
model
human
synovi
inflamm
seen
condit
could
relat
cytokin
releas
adjac
joint
capsul
direct
mechan
trauma
tissu
could
also
serv
initi
immun
condit
dendrit
cell
infiltr
earli
featur
islet
cell
autoimmun
diabet
mellitu
contribut
local
lymphoid
tissu
format
islet
cell
could
signal
dc
activ
autoimmun
diabet
destruct
process
direct
pancreat
cell
viral
tropism
cell
one
mechan
postul
initi
autoimmun
clue
dc
activ
signal
endocrin
diseas
gener
come
studi
thyroid
diseas
show
dc
infiltr
preced
metabol
abnorm
thyroid
gland
suggest
type
autoimmun
due
primari
abnorm
tissu
target
psoriasi
common
skin
condit
preval
skin
rich
sourc
langerhan
cell
thought
import
pathogenesi
inflamm
site
streptococc
bacteria
implic
pathogenesi
psoriasi
also
influenc
activ
statu
dc
recent
identifi
cutan
danger
signal
may
base
experi
show
mechan
stress
keratinocyt
result
liber
high
concentr
noteworthi
common
site
psoriasi
elbow
knee
skin
subject
consider
trauma
stretch
knowledg
central
role
dc
autoimmun
diseas
import
determin
mechan
action
current
avail
therapi
develop
futur
therapeut
strategi
studi
dc
support
activ
dc
phenotyp
autoimmun
diseas
studi
show
express
costimulatori
molecul
site
diseas
could
due
immunomodulatori
respons
site
reduc
sever
inflamm
howev
chang
interpret
repres
primari
defect
dc
function
could
theoret
allow
cell
clone
emerg
thymic
select
content
support
dc
abnorm
would
need
demonstr
prior
chronic
phase
respect
diseas
arm
immun
system
play
import
role
detect
elimin
malign
cell
lymphocyt
respons
tumour
cell
requir
initi
antigen
present
profession
apc
dc
dendrit
cell
infiltr
tumour
mani
year
link
increas
patient
surviv
reduct
number
metastas
varieti
malign
includ
endometri
gastric
lung
cancer
posit
prognost
indic
temper
observ
dc
isol
cancer
patient
show
impair
abil
present
antigen
product
decreas
surfac
express
costimul
also
appear
mani
sporad
tumour
activ
exploit
immunosuppress
pathway
interfer
antigen
present
act
directli
tissu
dc
prevent
matur
therefor
subsequ
immunogen
present
lymphocyt
increas
express
fasl
tumour
cell
may
also
induc
apoptosi
dc
cell
effector
vascular
endotheli
growth
factor
vegf
produc
major
carcinoma
shown
inhibit
matur
dc
within
tumour
impair
differenti
haemopoiet
progenitor
dc
vitro
studi
use
renal
cell
carcinoma
cell
line
shown
factor
releas
inhibit
differenti
dendrit
cell
progenitor
macrophag
subsequ
identifi
factor
mediat
inhibit
via
receptor
mechan
repres
parodi
normal
process
intend
establish
toler
tissu
immun
system
role
dc
pathogenesi
sporad
cancer
still
poorli
understood
great
deal
interplay
acquir
innat
arm
immun
system
allotransplant
howev
action
cytotox
cell
determin
whether
graft
surviv
reject
dc
abil
control
primari
lymphocyt
respons
therefor
initi
attack
allograft
present
alloantigen
tissu
damag
transplant
stress
host
graft
tissu
threshold
induc
dc
matur
via
releas
exampl
cytokin
activ
dc
migrat
away
graft
present
antigen
primarili
host
lymphoid
tissu
present
peptid
donor
dc
context
foreign
mhc
molecul
activ
helper
cytotox
cell
cytotox
cell
gener
alloantigen
move
circul
eventu
initi
attack
graft
cell
express
specif
peptid
present
dc
role
dc
graft
reject
exemplifi
observ
graft
surviv
dramat
increas
dc
deplet
addit
infus
dc
abl
prolong
life
similar
allograft
induc
cell
hyporespons
inde
pauciti
corneal
allotranspl
reject
thought
repres
low
level
dc
within
tissu
modul
cytokin
directli
affect
matur
dc
also
influenc
graft
surviv
exampl
blockad
signal
dc
shown
prolong
cardiac
graft
surviv
recent
studi
biolog
cytokin
shown
factor
induc
function
matur
dc
novel
antagonist
shown
promot
surviv
cardiac
graft
observ
dc
play
role
progress
sever
mani
diseas
led
mani
research
investig
modul
dc
function
could
use
therapeut
power
activ
dc
could
use
cancer
intracellular
parasit
infect
redirect
immun
respons
toward
defect
malign
infect
cell
evad
immunosurveil
figur
altern
dc
matur
could
suppress
allevi
symptom
autoimmun
allotranspl
reject
advanc
extract
vitro
cultur
dc
major
drive
forc
behind
recent
increas
interest
cell
facilit
inclus
power
adjuv
therapeut
trial
refin
laboratori
protocol
avail
either
gener
dc
number
readili
avail
sourc
direct
isol
dc
mix
cell
popul
cell
found
yield
dc
cultur
restrict
cocktail
cytokin
includ
stem
cell
monocyt
monocyt
perhap
readili
avail
precursor
use
gener
human
dc
constitut
human
pbmc
simplest
method
obtain
dc
allow
pbmc
adher
tissu
cultur
dish
h
sever
wash
adher
fraction
enrich
monocyt
immatur
dc
produc
use
effect
restrict
differenti
toward
myelomonocyt
lineag
inhibit
develop
macrophag
overal
result
forc
differenti
toward
dc
lineag
cell
obtain
vitro
cultur
high
dose
resembl
immatur
dc
high
affin
solubl
antigen
express
lower
level
costimulatori
molecul
activ
form
subsequ
addit
lp
cultur
dc
promot
matur
activ
would
expect
discuss
dc
life
histori
present
earlier
dc
cultur
also
obtain
immunomagnet
select
contamin
leucocyt
subset
deplet
cocktail
antibodi
cell
b
cell
nk
cell
monocyt
macrophag
leav
fraction
enrich
dc
altern
dc
posit
select
mix
cultur
use
antibodi
antigen
express
exampl
dendrit
immunotherapi
cancer
demonstr
number
studi
use
murin
tumour
establish
malign
rang
melanoma
mammari
carcinoma
success
regress
use
infus
activ
dc
gener
specif
ctl
requir
introduct
antigen
dc
thu
provid
target
immun
dc
abl
present
antigen
introduc
varieti
method
includ
plasmid
mrna
peptid
elut
synthet
cell
lysat
recombin
viral
vector
includ
adenoviru
vaccinia
viru
data
relat
human
dc
clinic
trial
scarc
certain
studi
report
encourag
result
one
studi
use
dc
puls
tumour
lysat
peptid
treatment
patient
metastat
melanoma
patient
immun
five
object
respons
two
subject
experienc
consider
diseas
regress
malign
melanoma
due
intrins
antigen
ideal
target
immunotherapi
publish
studi
use
dc
treatment
prostat
cancer
one
promis
cite
nine
patient
respond
immun
hsu
et
al
treat
patient
suffer
follicular
b
cell
lymphoma
dc
idiotyp
protein
result
mark
antitumour
immun
respons
four
patient
b
cell
lymphoma
presenc
truli
antigen
ideal
term
immunotherapi
reduc
autoimmun
complic
aris
coexpress
antigen
normal
tissu
exampl
patient
immun
antigen
eg
sometim
experienc
autoimmun
vitelligo
result
destruct
normal
melanocyt
autoreact
ctl
suspect
dc
immunotherapi
solid
tumour
consider
less
efficaci
melanoma
leukaemia
perhap
due
part
higher
incid
hla
antigen
dysregul
tumour
pauciti
good
antigen
increas
understand
dc
activ
allow
us
associ
danger
tumour
antigen
investig
cultur
dc
ex
vivo
tumour
immunotherapi
repres
consider
challeng
one
altern
may
use
infus
factor
directli
promot
dc
differenti
effort
increas
level
antitumour
immunosurveil
case
point
haemopoiet
growth
factor
growth
factor
shown
increas
number
dc
monocyt
peripher
blood
without
produc
seriou
side
effect
consequ
use
cytokinesgrowth
factor
adjuv
eg
abl
induc
protect
antitumour
immun
anim
model
thought
consequ
increas
present
tumour
antigen
combin
increas
nk
cell
activ
synergi
dc
factor
ligand
dc
activ
signal
tumour
necrosi
cytokin
tranc
may
provid
addit
benefit
promot
ctl
gener
alreadi
expand
pool
dc
respect
persist
viral
diseas
dc
function
could
modul
reactiv
silent
cell
lessen
effect
relaps
diseas
may
amen
form
intervent
includ
viral
hepat
hbv
hcv
papillomaviru
infect
chronic
hcmv
infect
optim
dc
therapi
persist
viral
diseas
hamper
lack
appropri
anim
model
howev
encourag
note
murin
model
chronic
hepat
mice
transgen
hepat
b
surfac
antigen
hbsag
toler
hbsag
broken
immun
dc
infer
earlier
discuss
dc
life
histori
immunotherapi
cancer
viral
diseas
dc
activ
member
tumour
necrosi
famili
ligand
eg
best
candid
break
immunolog
toler
situat
intracellular
parasit
interfer
dc
function
may
opportun
correct
defect
exampl
dc
secret
inhibit
leishmania
sp
prevent
effect
immun
respons
crucial
parasit
clearanc
infus
dc
combin
cytokin
may
help
reduc
parasit
burden
repolar
immun
suggest
possibl
therapi
hiv
could
involv
infus
dc
attempt
counter
suppress
immun
characterist
infect
convers
lymphocyt
could
anerg
direct
suppress
dc
activ
treatment
autoimmun
diseas
reduc
sever
allotranspl
reject
enhanc
abil
dc
toler
lymphocyt
could
accomplish
number
way
exampl
pretreat
dc
factor
one
recent
studi
shown
infus
ligand
increas
surviv
time
skin
allograft
administ
combin
factor
prevent
dc
activ
landmark
studi
found
dc
transfect
could
induc
toler
puls
peptid
previous
sensit
observ
provid
proof
may
also
possibl
delet
autoreact
cell
repertoir
use
modifi
dc
present
review
describ
understand
dc
biolog
provid
insight
coordin
innat
adapt
immun
import
cell
number
diseas
state
also
gradual
reveal
therefor
realist
near
futur
lineag
danger
toler
paradigm
fulli
resolv
possibl
modul
dc
function
consider
therapeut
benefit
would
like
offer
sincer
thank
stephen
richard
richard
jone
peter
cotterrel
construct
comment
regard
manuscript
laboratori
work
support
grant
yorkshir
cancer
research
arnold
tunstal
fellowship
medic
research
council
